Welcome to Law.com Class Actions: Critical Mass, a weekly briefing for class action and mass tort attorneys.

This week: What are lawyers saying about the U.S. Third Circuit’s decision dismissing the Chapter 11 case of Johnson & Johnson’s talc subsidiary? Valisure, the laboratory whose findings sparked Zantac and other recalls, is under scrutiny by both the defense bar and the U.S. Food and Drug Administration. Find out who else got appointed to lead the multidistrict litigation over Merck’s Gardasil.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]